EP
CDMO

Eversept Partners’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Eversept Partners’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100,402
Closed -$394K – 75
2018
Q2 		$394K Buy
+100,402
New +$348K 0.18% 63

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $2.82B AUM 13.66% 1-Year Est. Return

Eversept Partners's CDMO Position: Q3 2018 in Review

Eversept Partners sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2018, closing a stake of 100,402 shares — an estimated $394K sold.

Eversept Partners first reported a position in CDMO in Q2 2018 and held it in 1 quarter. The position peaked at $394K in Q2 2018. 101 funds tracked by Wall St. Rank hold CDMO as of Q3 2018.

  • Eversept Partners reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Eversept Partners sold 100,402 Avid Bioservices, Inc. Common Stock shares in Q3 2018, an estimated $394K.
  • Eversept Partners first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Eversept Partners's Avid Bioservices, Inc. Common Stock position peaked at $394K in Q2 2018.
  • 101 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2018.

Based on Eversept Partners's 13F filing for Q3 2018, filed 14 Nov 2018.